Giordano Nicoletti - Concepedia

Author

Giordano Nicoletti

Also Known As

G NICOLETTI, G Nicoletti, G. NICOLETTI, G. Nicoletti, Giordano Nicoletti, Giordano Nicoletti (278852), Nicoletti, Giordano, P Nanni

231

Publications

Citations

H-Index

Concepts

All Affiliations

University of Bologna Istituto Ortopedico Rizzoli University of Chieti-Pescara University of Turin IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

About

Giordano Nicoletti is an author at University of Bologna specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	57	2.7K
2	Health Sciences	5	5	180
3	Allergy	3	3	191
4	Biomolecular Engineering	2	2	50
5	Engineering	1	1	11

Giordano Nicoletti

102

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/<i>neu</i> Transgenic Mice K Boggio, Giordano Nicoletti, Emma Di Carlo, The Journal of Experimental Medicine	1998	300
Antitumor Activity of the Insulin-Like Growth Factor-I Receptor Kinase Inhibitor NVP-AEW541 in Musculoskeletal Tumors Katia Scotlandi, Maria Cristina Manara, Giordano Nicoletti, Cancer Research	2005	295
Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice Patrizia Nanni, Giordano Nicoletti, Carla De Giovanni, The Journal of Experimental Medicine	2001	232
TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma Patrizia Nanni, Carla De Giovanni, Pier‐Luigi Lollini, Clinical & Experimental Metastasis Malignant DiseaseMammary GlandPathologyBreast CancerMedicine	1983	224
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. Katia Scotlandi, Stefania Benini, Patrizia Nanni, PubMed Growth FactorMedicineImmunologyAthymic MiceCancer Cell Biology	1998	189
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis Anna Rocchi, Maria Cristina Manara, Marika Sciandra, Journal of Clinical Investigation	2010	177
NVP-BEZ235 as a New Therapeutic Option for Sarcomas Maria Cristina Manara, Giordano Nicoletti, Diana Zambelli, Clinical Cancer Research	2010	148
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling Cecilia Garofalo, Maria Cristina Manara, Giordano Nicoletti, Oncogene ImmunologyAnti-igf-1r TherapiesFibroblast Growth FactorInsulin ReceptorMedicine	2011	135
Preclinical <i>In vivo</i> Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma Maria Cristina Manara, Lorena Landuzzi, Patrizia Nanni, Clinical Cancer Research	2007	133
Virus-like particle display of HER2 induces potent anti-cancer responses Arianna Palladini, Susan Thrane, Christoph M. Janitzek, OncoImmunology ImmunologyHuman Her2ImmunotherapeuticsImmunotherapyVirus-like Particle Display	2017	120

Page 1